​

Lantheus (LNTH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LNTH Stock Forecast

Lantheus (LNTH) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $101.00, with a high of $110.00 and a low of $95.00. This represents a 19.77% increase from the last price of $84.33.

$60 $70 $80 $90 $100 $110 High: $110 Avg: $101 Low: $95 Last Closed Price: $84.33

LNTH Stock Rating

Lantheus stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (76.47%), 4 Hold (23.53%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 4 13 Strong Sell Sell Hold Buy Strong Buy

LNTH Price Target Upside V Benchmarks

TypeNameUpside
StockLantheus19.77%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.61%

Price Target Trends

1M3M12M
# Anlaysts249
Avg Price Target$96.50$98.00$85.11
Last Closing Price$84.33$84.33$84.33
Upside/Downside14.43%16.21%0.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26292--13
Mar, 26292--13
Feb, 26292--13
Jan, 26292--13
Dec, 25283--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 15, 2026Richard NewitterTruist Financial$98.00$82.6818.53%16.21%
Apr 13, 2026Anthony PetroneMizuho Securities$95.00$80.5018.01%12.65%
Mar 17, 2026Matthew TaylorJefferies$110.00$80.4536.73%30.44%
Feb 27, 2026Richard NewitterTruist Financial$89.00$74.9118.81%5.54%
Dec 18, 2025Truist Financial$82.00$65.3525.48%-2.76%
Dec 17, 2025Mizuho Securities$72.00$65.1710.48%-14.62%
Dec 11, 2025Richard NewitterTruist Financial$80.00$63.0926.80%-5.13%
Oct 08, 2025Goldman Sachs$77.00$51.8448.53%-8.69%
Aug 11, 2025Richard NewitterTruist Financial$63.00$56.0712.36%-25.29%
Dec 18, 2024Paul ChoiGoldman Sachs$143.00$91.1556.88%69.57%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 17, 2026William BlairOutperformOutperformhold
Mar 17, 2026JefferiesBuyBuyhold
Feb 27, 2026Seaport GlobalNeutralupgrade
Feb 26, 2026William BlairOutperformupgrade
Feb 24, 2026CitigroupOutperformOutperformhold
Oct 08, 2025Goldman SachsBuyNeutraldowngrade
Dec 18, 2024Goldman SachsBuyBuyinitialise
Sep 16, 2024Cowen & Co.BuyBuyhold
Aug 01, 2024JMP SecuritiesOutperformOutperformhold
Jul 25, 2024B. RileyBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.06$0.41$4.79$4.52$3.46---
Avg Forecast$0.41$3.84$5.92$6.74$7.01$7.82$8.73$11.28
High Forecast$0.44$4.10$6.01$6.94$7.66$9.11$10.70$12.41
Low Forecast$0.40$3.67$5.79$6.65$6.52$6.52$7.34$10.57
Surprise %-358.54%-89.32%-19.09%-32.94%-50.64%---

Revenue Forecast

$0 $600M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$425.21M$935.06M$1.30B$1.53B$1.54B---
Avg Forecast$407.40M$916.62M$1.28B$1.52B$1.61B$1.81B$2.10B$2.52B
High Forecast$426.48M$966.08M$1.29B$1.54B$1.73B$1.82B$2.10B$2.71B
Low Forecast$395.37M$887.05M$1.27B$1.51B$1.53B$1.81B$2.09B$2.40B
Surprise %4.37%2.01%1.13%0.88%-4.21%---

Net Income Forecast

$-100M $100M $300M $500M $700M $900M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-71.28M$28.07M$326.66M$312.44M$233.56M---
Avg Forecast$6.98M$33.67M$326.66M$477.52M$498.28M$517.16M$655.29M$792.30M
High Forecast$28.28M$55.24M$585.46M$487.68M$538.30M$639.92M$751.74M$871.79M
Low Forecast$-14.33M$12.11M$67.86M$467.36M$458.27M$458.12M$515.43M$742.59M
Surprise %-1121.86%-16.65%--34.57%-53.13%---

LNTH Forecast FAQ

Is Lantheus stock a buy?

Lantheus stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lantheus is a favorable investment for most analysts.

What is Lantheus's price target?

Lantheus's price target, set by 17 Wall Street analysts, averages $101 over the next 12 months. The price target range spans from $95 at the low end to $110 at the high end, suggesting a potential 19.77% change from the previous closing price of $84.33.

How does Lantheus stock forecast compare to its benchmarks?

Lantheus's stock forecast shows a 19.77% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (22.61%).

What is the breakdown of analyst ratings for Lantheus over the past three months?

  • April 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Lantheus’s EPS forecast?

Lantheus's average annual EPS forecast for its fiscal year ending in December 2026 is $7.82, marking a 126.01% increase from the reported $3.46 in 2025. Estimates for the following years are $8.73 in 2027, and $11.28 in 2028.

What is Lantheus’s revenue forecast?

Lantheus's average annual revenue forecast for its fiscal year ending in December 2026 is $1.81B, reflecting a 17.62% increase from the reported $1.54B in 2025. The forecast for 2027 is $2.1B, and $2.52B for 2028.

What is Lantheus’s net income forecast?

Lantheus's net income forecast for the fiscal year ending in December 2026 stands at $517.16M, representing an 121.42% increase from the reported $233.56M in 2025. Projections indicate $655.3M in 2027, and $792.3M in 2028.